NCT06134713

Brief Summary

The goal of this randomised clinical trial is to evaluate the effect of cryotherapy on postoperative pain after primary and secondary root canal treatment. The main question\[s\] it aims to answer are:

  • Dose cryotherapy help reduce postoperative pain after primary root canal treatment.
  • Dose cryotherapy help reduce postoperative pain after secondary root canal treatment. Participants will be randomly divided to receive either cryotherapy or irrigation with normal saline and the effect between the two groups in terms of postoperative pain will be compared after primary and secondary root canal treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started May 2023

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

10 months

First QC Date

November 4, 2023

Last Update Submit

November 11, 2023

Conditions

Keywords

Root Canal TreatmentPost Operative PainCryotherapyNonsurgical Root Canal Retreatment

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain assessment using the visual analog scale (VAS)

    Both pre- and postoperative pain will be assessed using the visual analog scale (VAS). According to the quantitative data obtained from the VAS scale (from 1 to 10), these values will be categorized as follows: no pain (0), slight pain (0.1-3.9), moderate pain (4-6.9) or severe pain (7-10)

    Preoperative, 6 hours,12 hours, 24 hours, 48 hours, 72 hours, 5 days and 7 days

Study Arms (4)

Root canal treatment cryotherapy group

EXPERIMENTAL

Conventional root canal treatment with final irrigation using sterile saline at 2.5ºC

Drug: cryotherapy with sterile saline at 2.5ºC

Root canal RE-treatment cryotherapy group

EXPERIMENTAL

Conventional root canal RE-treatment with final irrigation using sterile saline at 2.5ºC

Drug: cryotherapy with sterile saline at 2.5ºC

Root canal treatment control group

ACTIVE COMPARATOR

Conventional root canal treatment with final irrigation using sterile saline at room temperature

Drug: control with sterile saline at room temperature

Root canal RE-treatment control group

ACTIVE COMPARATOR

Conventional root canal RE-treatment with final irrigation using sterile saline at room temperature

Drug: control with sterile saline at room temperature

Interventions

In the cryotherapy (experimental group), final irrigation will be performed with 5 ml of 0.9% physiological sterile saline kept refrigerated at 2.5ºC and will be delivered for 1 or 4 minutes with a side vented needle inserted at working length for each canal.

Root canal RE-treatment cryotherapy groupRoot canal treatment cryotherapy group

In the control group, final irrigation will be performed with 5 ml of 0.9% physiological sterile saline kept at room temperature and will be delivered for 1 or 4 minutes with a side vented needle inserted at working length for each canal.

Root canal RE-treatment control groupRoot canal treatment control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years.
  • Patients who demonstrate understanding of the study and willingness to participate as evidenced by signing the voluntary informed consent and who received a signed and dated copy of the informed consent form.
  • Patients who understand and are willing to comply with all study procedures and restrictions.
  • Absence of clinically significant and relevant abnormalities in the clinical history or oral examination.
  • Endodontic treatment considered the treatment of choice for both multi and single rooted teeth.
  • Endodontic retreatment considered the treatment of choice only in posterior molar teeth (multirooted).
  • Only one treatment per patient.

You may not qualify if:

  • Patients who are allergic to any of the materials used in the treatment.
  • Patients with heart pacemaker.
  • Patients with any general pathology that requires antibiotic prophylaxis.
  • Root resorption, root fractures, impossibility of restoration.
  • Pregnant patients.
  • Patients who took painkillers in the last 6 hours.
  • Case where apical patency couldn't be achieved
  • Cases where final obturation quality is compromised.
  • Any intra operative factor that complication that can compromise the treatment outcome like root perforation or fractured instrument or inability to localize/prepare any canal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ajman University

Ajman, United Arab Emirates

Location

MeSH Terms

Conditions

Tooth, NonvitalPain, Postoperative

Interventions

Cryotherapy

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Firas H Elmsmari, PhD

    Ajman University - College of Dentistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 4, 2023

First Posted

November 18, 2023

Study Start

May 15, 2023

Primary Completion

February 28, 2024

Study Completion

May 30, 2024

Last Updated

November 18, 2023

Record last verified: 2023-11

Locations